<DOC>
	<DOC>NCT01179191</DOC>
	<brief_summary>The purpose of the research study is to find out if opioid dependent chronic pain patients who are judged by their physician to be eligible to change their current opioid medicine and to participate in this study can be successfully adjusted to a stable dose of EMBEDA (morphine sulfate and naltrexone hydrochloride). The study will also assess each patient's risk for prescription opioid abuse, misuse and diversion.</brief_summary>
	<brief_title>Conversion to Embeda With Rescue Trial</brief_title>
	<detailed_description>The decision to terminate the trial was based on a lack of study drug supply. The decision was not based on any safety concerns. The termination letter was sent on 11March2011.</detailed_description>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Be able to read, speak and understand English Have chronic moderate to severe pain for at least 3 months Require around the clock opioid medication for the relief of pain Have been taking a daily opioid for at least 30 days prior to starting the study Be able to be safely switched to a different pain medication Be practicing acceptable birth control methods for female patients of childbearing potential Be willing to participate in the study and able to comply with study procedures Be currently diagnosed with or participating in and/or seeking treatment for opioid and/or alcohol abuse Be allergic or intolerant to morphine, morphine salts, naltrexone or other opioids Be currently taking tramadol and/or extended release morphine products Have respiratory depression Have acute or severe bronchial asthma or severe chronic obstructive pulmonary disease Have migraines as your main source of pain Have any form of bowel obstruction Be pregnant or breast feeding Have had 2 or more surgeries for low back pain Be planning a major surgery during the study Be staying in a hospital or nursing home Be planning to have steroid injections for your chronic pain during the study Have a life expectancy of less than 2 months</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>chronic pain</keyword>
	<keyword>Embeda</keyword>
	<keyword>opioid</keyword>
	<keyword>moderate pain</keyword>
	<keyword>severe pain</keyword>
	<keyword>conversion</keyword>
	<keyword>converting</keyword>
	<keyword>switching</keyword>
	<keyword>morphine</keyword>
	<keyword>aberrant behavior</keyword>
	<keyword>Pain (DT) + Chronic Disease (DT)</keyword>
</DOC>